Clinical trial
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced…
NCT00408655 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00408655 |
|---|---|
| Title | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of CCI-779 (NSC 683864) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Sarcoma, Ovarian Stromal Cancer, Recurrent Endometrial Carcinoma, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Stage III Endometrial Carcinoma, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Endometrial Carcinoma, Stage IV Ovarian Epithelial Cancer and 3 more |
| Intervention type | Drug |
| Interventions | paclitaxel, carboplatin, temsirolimus |
| Enrollment | 38 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2012 |
| First posted | Dec 7, 2006 |
| Last update posted | Jun 19, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: